🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
This is a single cohort observational safety study. All patients will be tr...
Status
Completed
Location
Lkh-Univ. Klinikum Graz; Klinik Für Gynäkologie
Start Date
2007-08-30
Trial ID
NCT01152606
Treatments Being Tested
Clinicians are currently proposing second-line hormonal treatment to a meta...
Status
Unknown
Location
Institut de Cancerologie de l'Ouest
Start Date
2017-03-15
Trial ID
NCT03442504
Treatments Being Tested
CYPTAM-BRUT 3 is a prospective, multicentric study in Belgium within the CY...
Status
Completed
Location
AZ St-Maarten
Start Date
2009-06
Trial ID
NCT00966043
VENTANA is a "window-of-opportunity" trial that will explore whether, simil...
Status
Completed
Location
Hospital Universitari Vall d'Hebron
Start Date
2016-07
Trial ID
NCT02802748
Treatments Being Tested
RATIONALE: Drugs used in chemotherapy, such as doxorubicin, cyclophosphamid...
Status
Active Not Recruiting
Location
Regional Medical Center
Start Date
2003-11
Trial ID
NCT00070564
Treatments Being Tested
The purpose of this research study is to find out what effects (good and ba...
Status
Completed
Location
Birmingham Hematology and Oncology
Start Date
2007-06
Trial ID
NCT00493649
This study consists of two parts. Part 1 is a dose-escalation/safety evalua...
Status
Terminated
Location
University of Alabama at Birmingham
Start Date
2017-05-12
Trial ID
NCT03134638
Patients with metastatic breast cancer may respond well to treatment and me...
Status
Active Not Recruiting
Location
Department of Oncology, Sahlgrenska University Hospital
Start Date
2019-05-08
Trial ID
NCT04597580
The current study is a multicentre, randomized,double-blind, prospective cl...
Status
Unknown
Location
The First Affiliated Hospital of Guangzhou Medical University
Start Date
2014-05
Trial ID
NCT02062489
RATIONALE: Monoclonal antibodies, such as trastuzumab, can block tumor grow...
Status
Completed
Location
Kantonspital Aarau
Start Date
2005-05
Trial ID
NCT00238290
Treatments Being Tested